Literature DB >> 7714681

Fortification of human milk: evaluation of a novel fortification scheme and of a new fortifier.

G E Moro1, I Minoli, M Ostrom, J R Jacobs, T A Picone, N C Räihä, E E Ziegler.   

Abstract

Human milk fed to very-low-birth-weight infants must be fortified with protein, minerals, and vitamins. We tested a new fortification regimen in which the amount of fortifier was adjusted on the basis of frequent determinations of serum urea nitrogen (SUN). A newly formulated fortifier based on bovine milk proteins was employed either in the new fashion (regimen ADJ) or in the conventional fixed proportion (regimen FIX). Using the fixed proportion, the study also compared the new fortifier with a fortifier based on human milk protein (regimen HMP). Twelve infants were studied with each of the three regimens; nearly all completed 3 weeks of study. Protein intake was generally higher in ADJ than FIX; the difference was significant (p < 0.01) during week 2. Weight gain was somewhat (but not significantly) greater in regimen ADJ (32.3 g/d or 18.8 g/kg/d) than in regimen FIX (30.0 g/d or 18.3 g/kg/d). SUN was higher in ADJ than in FIX, and several other serum chemical values (calcium, phosphorus, potassium) tended to be higher, probably reflecting higher intakes of these nutrients with ADJ than with FIX. Plasma concentrations of several amino acids were higher in ADJ than FIX, but none, including threonine, were outside the physiological range. In comparing regimen FIX to regimen HMP, infants on FIX received similar intakes of protein and showed slightly but not significantly more rapid weight gain. Concentrations of SUN were lower with FIX, but other serum chemical values, including amino acids, were generally similar to HMP. We conclude that use of the new adjustable fortification regimen is feasible and safe and that it should be studied further. It produced the expected increases in nutrient intakes and growth. The new bovine milk-based fortifier appears to be equivalent to the human milk-based fortifier.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7714681     DOI: 10.1097/00005176-199502000-00005

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  6 in total

1.  Docosahexaenoic and arachidonic acid content of serum and red blood cell membrane phospholipids of preterm infants fed breast milk, standard formula or formula supplemented with n-3 and n-6 long-chain polyunsaturated fatty acids.

Authors:  G Boehm; M Borte; H J Böhles; H Müller; G Kohn; G Moro
Journal:  Eur J Pediatr       Date:  1996-05       Impact factor: 3.183

2.  What should be the protein target for adjustable Human Milk fortification in premature infants?

Authors:  Bayram Ali Dorum; Hilal Ozkan; Salih Cagri Cakir; Nilgun Koksal; Gizem Ezgi Sen
Journal:  Pak J Med Sci       Date:  2019 Jan-Feb       Impact factor: 1.088

3.  Individualized versus standard diet fortification for growth and development in preterm infants receiving human milk.

Authors:  Veronica Fabrizio; Jennifer M Trzaski; Elizabeth A Brownell; Patricia Esposito; Shabnam Lainwala; Mary M Lussier; James I Hagadorn
Journal:  Cochrane Database Syst Rev       Date:  2020-11-23

Review 4.  Protein Intake and Growth in Preterm Infants: A Systematic Review.

Authors:  Emma L Tonkin; Carmel T Collins; Jacqueline Miller
Journal:  Glob Pediatr Health       Date:  2014-10-15

5.  Commencing Nutrient Supplements before Full Enteral Feed Volume Achievement Is Beneficial for Moderately Preterm to Late Preterm Low Birth Weight Babies: A Prospective, Observational Study.

Authors:  Wei Qi Fan; Amy Gan; Olivia Crane
Journal:  Nutrients       Date:  2018-09-20       Impact factor: 5.717

Review 6.  Using Nature to Nurture: Breast Milk Analysis and Fortification to Improve Growth and Neurodevelopmental Outcomes in Preterm Infants.

Authors:  Katherine Marie Ottolini; Elizabeth Vinson Schulz; Catherine Limperopoulos; Nickie Andescavage
Journal:  Nutrients       Date:  2021-11-29       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.